| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.17 | 0.004 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.25 | 0.004 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.007 |